- Home
- NVVEW vs SIGA Comparison
NVVEW vs SIGA Comparison
Compare NVVEW & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVVEW | SIGA |
|---|---|---|
| Founded | N/A | 1995 |
| Country | China | United States |
| Employees | 12 | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 462.6M |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | NVVEW | SIGA |
|---|---|---|
| Price | $0.01 | $6.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | ★ 345.3K |
| Earning Date | N/A | 11-06-2025 |
| Dividend Yield | N/A | ★ 9.57% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | ★ $172,249,641.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $132.36 |
| P/E Ratio | ★ N/A | $6.09 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | N/A | $4.95 |
| 52 Week High | N/A | $9.62 |
Technical Indicators
Market Signals| Indicator | NVVEW | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 46.73 | 43.82 |
| Support Level | $0.01 | $6.22 |
| Resistance Level | $0.02 | $6.45 |
| Average True Range (ATR) | 0.00 | 0.19 |
| MACD | -0.00 | 0.08 |
| Stochastic Oscillator | 57.33 | 56.59 |
Price Performance
Historical ComparisonAbout NVVEW Nuvve Holding Corp. Warrant
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.